STRO - Chief Business Officer of Sutro Biopharma Sold $53K In Stock | Benzinga
Brunilda Shtylla, Chief Business Officer at Sutro Biopharma (NASDAQ:STRO), reported a large insider sell on August 28, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Shtylla sold 11,613 shares of Sutro Biopharma. The total transaction amounted to $53,281.
Sutro Biopharma shares are trading up 0.63% at $4.77 at the time of this writing on Tuesday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to ...